Pharmeasy buys Medlife, creates India s largest online pharmacy
SECTIONS
Last Updated: May 25, 2021, 03:05 PM IST
Share
Synopsis
Pharmeasy said that Medlife would discontinue its operations and would be merged with its own platform from May 25
ETtech
Illustration: Rahul Awasthi
Mumbai-based Pharmeasy on Tuesday announced the acquisition of its smaller rival Medlife. This is the largest consolidation deal in India’s fast-growing online pharmacy sector, and comes as
Reliance, Tata and Amazon are all vying for a share of the market.
“This will make us the largest healthcare delivery platform across the country by a distance serving more than two million families every single month,” Dhaval Shah, co-founder of Pharmeasy, wrote on Linkedin.
Pharmeasy parent enters unicorn club at $1.5 billion valuation
SECTIONS
Share
Synopsis
Pharmeasy’s $350 million funding round comes at a time when Reliance, Tata Group and Amazon are looking to tap the online pharmacy business by way of acquisitions.
ETtech
Pharmaeasy is the seventh startup unicorn this year, after Cred, Meesho, Digit Insurance, Innovaccer, Infra.Market and Five Star Finance. (Illustration: Rahul Awasthi/ETtech)
Bengaluru: Prosus Ventures and US-based private equity firm TPG Capital are leading an investment of $350 million (about Rs 2,570 crore) in API Holdings, the parent company of Mumbai-based online pharmacy Pharmeasy.
Prosus Ventures (previously Naspers Ventures) is the venture investing arm of South African technology and media conglomerate Prosus, which is one of the largest investors in Indian technology startups including Swiggy, Byju s and Meesho.